Alison Burklund

Executive Officer, Director at Nanopath.

Raised on Nanopath filings

$5.3M

of $6M offered across 1 Form D filing

Form D filings: 1
Teammates: 3
Last filing: Feb 6, 2025

Company

Healthcare · Cambridge, MA

Rapid molecular tests for women's health

Rapid molecular tests for women's health

Investors: 5
Still open: $659K

Investors: 5
Sector: Healthcare
HQ: Cambridge, MA

Nanopath filings

Nanopath Form D filings
Filed	Security	Sold of offered	Filing
Feb 6, 2025	Debt	$5.3M/ $6M	Form D

DebtFiled Feb 6, 2025Form D
$5.3M/ $6M

Works with

Also named on Nanopath filings

Amogha TadimetyCo-Chief Executive Officer, Form D signerForm D signer Aaron SandoskiDirector Jeff CroweDirector